Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | -38,405 | 68,217 | 54,617 | 47,407 | 50,983 |
| Cost of Goods | -1,070 | 1,592 | 1,651 | 1,645 | 2,073 |
| Gross Profit | -37,335 | 66,625 | 52,966 | 45,762 | 48,910 |
| Operating Expenses | 47,445 | 98,928 | 88,932 | 93,956 | 167,533 |
| Operating Income | -84,850 | -31,711 | -35,315 | -47,549 | -118,550 |
| Interest Expense | 4,610 | 4,899 | 4,852 | 5,321 | 4,762 |
| Other Income | 690 | 1,014 | 1,204 | -684 | 1,219 |
| Pre-tax Income | -88,770 | -35,596 | -38,963 | -53,554 | -122,093 |
| Income Tax | 4 | 43 | 49 | 313 | -471 |
| Net Income Continuous | -88,774 | -35,639 | -39,012 | -53,867 | -121,622 |
| Net Income | $-51,573 | $-35,639 | $-39,012 | $-53,867 | $-121,622 |
| EPS Basic Total Ops | -0.82 | -0.59 | -0.64 | -0.96 | -2.56 |
| EPS Basic Continuous Ops | -1.44 | -0.59 | -0.64 | -0.96 | -2.56 |
| EPS Diluted Total Ops | -0.82 | -0.59 | -0.64 | -0.96 | -2.56 |
| EPS Diluted Continuous Ops | -1.44 | -0.59 | -0.64 | -0.96 | -2.56 |
| EBITDA(a) | $-87,777 | $-21,004 | $-26,087 | $-38,561 | $-109,758 |